The Indian Government has approved the use of Gilead Sciences Inc’s novel drug Remdesivir for emergency use to treat COVID-19 patients on June 2.
Lav Aggarwal, Joint Secretary in the Health Ministry confirmed that the Drug Controller General of India VG Somani has given green signal to the emergency use for five doses of Remdesivir to treat COVID-19 patients.
“(Remdesivir) approved on June 1 under emergency use with condition for five dose administration,” the Drugs Controller General of India said in an email statement.
Lav Aggarwal said, “The DCGI gave an emergency use permission for remdesivir… and this was based on evidence that was provided by the company to support its use against COVID-19.”
In May, the US Food and Drug Administration granted emergency use authorisation to Remdesivir and the drug has even received the approval by Japanese health regulators. Remdesivir is being administered in some countries under compassionate use rules.
The drug has shown positive result in treating the COVID-19 which by far has no vaccine available.
Photo Credit : https://commons.wikimedia.org/wiki/File:Remdesivir.svg